Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,624.70
(
-1.36%
)
US TECH 100
23,736.80
(
-1.64%
)
Dow Jones
46,225.15
(
-1.63%
)
Brent Oil
107.94
(
7.24%
)
Bitcoin
71,268.45
(
-3.62%
)
News Focus
News Focus
Post# of 257254
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 842
Posts 122793
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: DewDiligence post# 155812

Tuesday, 01/29/2013 3:21:26 PM

Tuesday, January 29, 2013 3:21:26 PM

Post# of 257254
Curious error in SA transcript of BMY CC:

http://seekingalpha.com/article/1131001-bristol-myers-squibb-s-ceo-discusses-q4-2012-results-earnings-call-transcript

(Lamberto Andreotti, CEO): Eliquis has a real differentiated profile, and we were very encouraged to see the approvals in different parts of the world, reflects the risk rate action versus Warfarin in all three important outcomes of strong reduction, nasal bleeding and all because of that. So good clinical data and labels reflecting that clinical data.

The word nasal should be major, which is not that close in sound.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now